12. The technician is asked to use Tall Man lettering when making a bin label for a new product because:
Answer: A
This contributes to patient safety.
Tall Man lettering is utilized specifically to enhance clarity and reduce the risk of medication errors, thereby contributing to patient safety.
A) this contributes to patient safety.
This option is correct as the primary purpose of Tall Man lettering is to minimize confusion between similar-sounding or similar-looking drug names, which directly impacts patient safety by reducing the likelihood of medication errors.
B) it is an FDA requirement.
This option is incorrect because, while the FDA encourages the use of Tall Man lettering, it is not a strict requirement. The use of this lettering is a recommended practice rather than a mandated one.
C) all generic drug labels include this labeling.
This option is incorrect as not all generic drug labels utilize Tall Man lettering. The application of this technique varies and is not universally applied to all generic medications.
D) it is only used for clinical trial products.
This option is incorrect because Tall Man lettering is not exclusive to clinical trial products. It is used in various settings to enhance safety across both clinical and regular pharmaceutical products.
Conclusion
The use of Tall Man lettering primarily serves to enhance patient safety by reducing the risk of medication errors associated with look-alike and sound-alike drug names. The other options either misrepresent the purpose or scope of Tall Man lettering, making option A the definitive correct answer.